Vas Narasimhan

Cholesterol Drug Setback Jolts Multibillion-Dollar Race: Novartis Trial Failure Casts Shadow on Rivals

Novartis' experimental cholesterol drug, pelacarsen, has failed to reduce cardiovascular events in a critical…